Ustekinumab 90mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £32,121,911 of indicative cost of Ustekinumab 90mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 459.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ustekinumab 90mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ustekinumab 90mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| St George's Univ Hosps Foundation Nhst | £1,953,555 |
| Somerset P/Ship Nhs Foundation Trust | £1,768,055 |
| Dorset County Hpl Nhs Foundation Trust | £1,686,898 |
| Leeds Teaching Hpls Nhs Trust | £1,634,726 |
| London North West Healthcare Nhs Trust | £1,297,862 |
| Torbay And South Devon Nhs Foundation Tr | £1,120,734 |
| North West Anglia Nhs Foundation Trust | £1,074,359 |
| University Hpls Of Leicester Nhs Trust | £1,026,695 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,022,187 |
| South Warwickshire Nhs Foundation Trust | £981,608 |
The primary-care picture
Ustekinumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ustekinumab medicine page.